McKesson : OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson -September 20, 2023 at 09:07 am EDT

CARY, N.C., Sept. 20, 2023-Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by GSK as a specialty pharmacy provider for...

Related Keywords

Claire Crye ,Mckesson Corporation ,Specialty Pharmacy Solutions ,Mckesson ,Drug Administration ,Ela Lourido ,Hematol Oncol ,Myelofibrosis Related Anemia ,Emerging Therapeutic ,Markets ,